Abstract: To provide a syringe with a needle storage mechanism in which the needle storage mechanism is not activated before use. A safety syringe including an injection barrel 1 having a connecting portion 11 at the distal end and an opening at the proximal end thereof, a needle assembly B having an injection needle 5 and a needle base 6 fixed to the proximal end of the injection needle 5 and being connected to the connecting portion 11, a gasket 2 provided liquid-tightly and slidably in the injection barrel, a plunger 3 being connected to the proximal end of the gasket 2 and joining means 21 provided at the distal portion of the gasket 2 or the plunger 3, and joined means 61 provided at the proximal portion of the needle base 6, wherein a joint preventing means 90 which prevents the joining means 21 and the joined means 61 from being joined unintentionally before use, and allows joining to each other when in use is provided.

Abstract: A gasket is provided with a female screw hole formed as a recess from a base end toward a leading end. The female screw hole includes a shaft receiving hole and a screw groove formed in the shaft receiving hole. The shaft receiving hole has a diameter gradually reduced from the base end. The gasket is also applicable for a plunger, a syringe, and a prefilled syringe, and the gasket may include a looseness prevention mechanism.

Abstract: A cellular electric potential measuring container includes a container body and an electrode substrate, the electrode substrate being attached to a lower end of the container body so as to form a plurality of wells. The container body is made from resin and comprises a plurality of tubular portions whose upper and lower ends are open, each of the tubular portions comprises in an inner cavity a measurement portion tapered toward the lower end and having a measurement hole at the lower end, and further on an inner wall at least two retaining means retaining the measurement portion. The electrode substrate comprises a substrate body, with a plurality of measurement electrodes and a plurality of reference electrodes being disposed on one surface of the substrate body. The container body is attached to the surface of the substrate body on which the measurement electrodes and the reference electrodes are disposed, such that the measurement electrodes are exposed through the measurement holes.

Abstract: A nasal cavity administration container includes a body section including a medical fluid storage section having an opening and a plunger having a pressing part, and a plunger moving amount regulation member having a stopper and being engaged with the body section, an engagement with the body section being relieved only in a state where the pressing part abuts on the stopper. When the plunger is pushed into the medical fluid storage section, the plunger moves forward until the pressing part abuts on the stopper. The plunger is further pushed into the medical fluid storage section with the plunger moving amount regulation member detached from the body section. The nasal cavity administration container can administer a medical fluid easily and appropriately.

Abstract: A liquid agent container includes the container's main unit, a cap, an intermediate member, and an internal stopper. The cap is provided with a liquid agent discharging path and an air introducing path. The intermediate member has a tube projecting toward the interior of the main unit. Between a liquid agent introducing path and the liquid agent discharging path a hydrophilic filter is provided, and between an air supplying path communicating with the air introducing path and an air delivering path a filter is provided. The air delivering path communicates with the interior of the main unit via a check valve, with an annular valve having an inner circumferential surface in contact with an outer circumferential surface of the tube, to pass air only in a direction toward the interior of the main unit. The present invention can provide a liquid agent container including a check valve readily fabricated and ensuring preventing a liquid agent from flowing back.

Abstract: There is provided a method for manufacturing a double-chamber container including an agent storage chamber and a solution storage chamber separated from each other by a weak seal portion, the method including the steps of: preparing a first sheet-like member including a first agent storage chamber forming portion and a first solution storage chamber forming portion whose one sides are joined to each other, as well as a second sheet-like member including a second agent storage chamber forming portion and a second solution storage chamber forming portion whose one sides are joined to each other; and forming the agent storage chamber and the solution storage chamber by joining the first and the second sheet-like members. The weak seal portion is formed by joining the one side of the first medical solution storage chamber forming portion and the one side of the second medical solution storage chamber forming portion.

Abstract: A gasket includes a flexible packing portion having a recess attached to a coupler of a plunger rod, and a core member harder than the packing portion. The recess has an internal circumferential surface with an internally threaded portion capable of being screwed on and thus engaging with an externally threaded portion provided on an external circumferential surface of the coupler. The core member has a helical shape defining the internal circumferential surface of the recess and the internally threaded portion provided on the internal circumferential surface. The packing portion defines a sliding surface brought into contact with an inner circumferential surface of a barrel, and the packing portion also covers an outer circumferential surface of the core member.

Abstract: A bottomed, tubular hollow elastic body that opens toward an outlet side of a drug solution flow path is accommodated and arranged in an accommodation part formed in a housing, and a middle protrusion is provided protruding toward an inlet side of the drug solution flow path from a center part of a bottom wall of the hollow elastic body. Insertion of a male luer causes the bottom wall of the hollow elastic body to be elastically deformed so as to enter inside a peripheral wall, increasing the volume of the drug solution flow path, which is formed between an outer surface of the hollow elastic body and an inner surface of the accommodation part. Removing the male luer and canceling the elastic deformation of the hollow elastic body causes the volume of the drug solution flow path to be reduced.

Abstract: A balloon catheter of novel configuration, which is capable of both efficiently heating a heating element by using a laser light and of ensuring durability by avoiding the laser light directly heating members other than the heating element. Provided is a balloon catheter with a balloon disposed in a distal end section of a shaft and wherein: a tightly wound coil shaped heating element is housed and arranged in the balloon; an optical fiber that irradiates a laser light inside the heating element is disposed; and a supply path that supplies a fluid to inside the balloon through an inside of the heating element and a discharge path that discharges the fluid from inside the balloon through a discharge port positioned on an outside of the heating element are disposed.

Abstract: A connection port 31 includes a cylindrical outer port 42 to which downstream piping 30b (discharge-side piping) is connected; an inner port 43 to which upstream piping 30a (supply-side piping) is connected, and which is provided in the outer port; and a lid member 44 which closes the inner port as well as the outer port. The inner port is provided so as to extend through the outer port from the outside of the outer port, and a heater H is provided on a portion of the inner port projecting outside the outer port. When the lid member is in a closed state, the inner port is heated with the heater to sterilize the portion of the inner port exposed to the outside, thus enabling the connection port to be cleaned at a higher level.

Abstract: The invention provides a method for sterilizing a blood purifier, as well as a blood purifier package. The method is effective to decrease the amounts of extracts from the blood purifier attributed to the deterioration of the selectively permeable separation membranes with time during and after exposure to a radioactive ray or an electron ray, and is highly reliable in safety when employed for hemocatharsis therapy. The method for sterilizing a blood purifier which comprises substantially dried selectively permeable separation membranes as a main component, by way of the exposure of the same blood purifier to a radioactive ray and/or an electron ray, is characterized in that the blood purifier is sealed in a packaging bag, together with an oxygen scavenger and a humectant or together with an oxygen scavenger capable of releasing a moisture, and is then sterilized in such a sealed state by the above exposure.